10:08 AM
 | 
Feb 28, 2018
 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Parkinson’s disease (PD)

Rat studies suggest non-catechol-based dopamine D1 receptor agonists could help treat PD more effectively than catechol-based agonists. High throughput screening of about 3 million compounds in an in vitro activity assay identified a non-catechol compound that agonized D1...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >